Lundbeck to buy Chelsea Therapeutics for up to $658M


Chelsea Therapeutics (CHTP) has agreed to sell itself to Lundbeck (HLUKF) for as much as $658M, with the offer of up to $7.94 a share representing a premium of 59% over Chelsea's closing price yesterday of $5. (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs